These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 36261701

  • 1. Nonfunctioning adrenal incidentalomas with cortisol post-dexamethasone suppression test >0.9 µg/dL have a higher prevalence of cardiovascular disease than those with values ≤0.9 µg/dL.
    Araujo-Castro M, Parra Ramírez P, Martín Rojas-Marcos P, García Centeno R, Gracia Gimeno P, Tomé Fernández-Ladreda M, Sampedro Núñez MA, Higueruela C, Robles Lázaro C.
    Endocrine; 2023 Feb; 79(2):384-391. PubMed ID: 36261701
    [Abstract] [Full Text] [Related]

  • 2. Cardiometabolic profile of non-functioning and autonomous cortisol-secreting adrenal incidentalomas. Is the cardiometabolic risk similar or are there differences?
    Araujo-Castro M, Robles Lázaro C, Parra Ramírez P, Cuesta Hernández M, Sampedro Núñez MA, Marazuela M.
    Endocrine; 2019 Dec; 66(3):650-659. PubMed ID: 31473918
    [Abstract] [Full Text] [Related]

  • 3. Is the 1mg-dexamethasone suppression test a precise marker of glucocorticoid excess and cardiometabolic risk in patients with adrenal incidentalomas?
    Araujo-Castro M, Hanzu FA, Pascual-Corrales E, García Cano AM, Marchan M, Escobar-Morreale HF, Valderrabano P, Casals G.
    Endocrine; 2023 Oct; 82(1):161-170. PubMed ID: 37351760
    [Abstract] [Full Text] [Related]

  • 4. Adrenalectomy improves blood pressure control in nonfunctioning adrenal incidentalomas and glycemic and lipid control in patients with autonomous cortisol secretion.
    Araujo-Castro M, Mínguez Ojeda C, Sánchez Ramírez MN, Gómez Dos Santos V, Pascual-Corrrales E, Fernández-Argüeso M.
    Endocrine; 2022 Oct; 78(1):142-150. PubMed ID: 35751779
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Patients with apparently nonfunctioning adrenal incidentalomas may be at increased cardiovascular risk due to excessive cortisol secretion.
    Androulakis II, Kaltsas GA, Kollias GE, Markou AC, Gouli AK, Thomas DA, Alexandraki KI, Papamichael CM, Hadjidakis DJ, Piaditis GP.
    J Clin Endocrinol Metab; 2014 Aug; 99(8):2754-62. PubMed ID: 24712565
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Adrenal incidentaloma: Do patients with apparently nonfunctioning mass or autonomous cortisol secretion have similar or different clinical and metabolic features?
    Rebelo JFD, Costa JM, Junqueira FD, Fonseca AO, de Almeida ABABS, Moraes AB, Vieira Neto L.
    Clin Endocrinol (Oxf); 2023 May; 98(5):662-669. PubMed ID: 36514987
    [Abstract] [Full Text] [Related]

  • 10. Relationship Between Dexamethasone Suppression Test Cortisol Level >0.9 μg/dL and Depression and Quality of Life in Adrenal Incidentalomas: A Single Center Observational Case-Control Study.
    Güneş M, Güneş E, Kaya Mİ, Küçükelyas HD, Barut H, Öner S.
    Endocr Pract; 2024 Aug; 30(8):710-717. PubMed ID: 38729569
    [Abstract] [Full Text] [Related]

  • 11. Clinical features, risk of mass enlargement, and development of endocrine hyperfunction in patients with adrenal incidentalomas: a long-term follow-up study.
    Falcetta P, Orsolini F, Benelli E, Agretti P, Vitti P, Di Cosmo C, Tonacchera M.
    Endocrine; 2021 Jan; 71(1):178-188. PubMed ID: 32915435
    [Abstract] [Full Text] [Related]

  • 12. Predictive model for autonomous cortisol secretion development in non-functioning adrenal incidentalomas.
    Araujo-Castro M, García Cano AM, Escobar-Morreale HF, Valderrabano P.
    Hormones (Athens); 2023 Mar; 22(1):51-59. PubMed ID: 36279032
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Adrenal incidentaloma as a novel independent predictive factor for periodontitis.
    Rodrigues MO, Moraes AB, de Paula MP, Pereira VA, Leão ATT, Vieira Neto L.
    J Endocrinol Invest; 2021 Nov; 44(11):2455-2463. PubMed ID: 33788166
    [Abstract] [Full Text] [Related]

  • 15. Possible, probable, and certain hypercortisolism: A continuum in the risk of comorbidity.
    Araujo-Castro M, Pascual-Corrales E, Lamas C.
    Ann Endocrinol (Paris); 2023 Apr; 84(2):272-284. PubMed ID: 36736771
    [Abstract] [Full Text] [Related]

  • 16. Cortisol level after dexamethasone suppression test in patients with non-functioning adrenal incidentaloma is positively associated with the duration of reactive hyperemia response on microvascular bed.
    de Paula MP, Moraes AB, de Souza MDGC, Cavalari EMR, Campbell RC, Fernandes GDS, Farias MLF, Mendonça LMC, Madeira M, Bouskela E, Kraemer-Aguiar LG, Vieira Neto L.
    J Endocrinol Invest; 2021 Mar; 44(3):609-619. PubMed ID: 32686043
    [Abstract] [Full Text] [Related]

  • 17. Concomitant alterations of metabolic parameters, cardiovascular risk factors and altered cortisol secretion in patients with adrenal incidentalomas during prolonged follow-up.
    Papanastasiou L, Alexandraki KI, Androulakis II, Fountoulakis S, Kounadi T, Markou A, Tsiavos V, Samara C, Papaioannou TG, Piaditis G, Kaltsas G.
    Clin Endocrinol (Oxf); 2017 Apr; 86(4):488-498. PubMed ID: 27992961
    [Abstract] [Full Text] [Related]

  • 18. The prevalence and characteristics of non-functioning and autonomous cortisol secreting adrenal incidentaloma after patients' stratification by body mass index and age.
    Podbregar A, Janez A, Goricar K, Jensterle M.
    BMC Endocr Disord; 2020 Jul 31; 20(1):118. PubMed ID: 32736549
    [Abstract] [Full Text] [Related]

  • 19. Bone Evaluation by High-Resolution Peripheral Quantitative Computed Tomography in Patients With Adrenal Incidentaloma.
    Moraes AB, de Paula MP, de Paula Paranhos-Neto F, Cavalari EMR, de Morais FFC, Curi DSC, Lima LFC, de Mendonça LMC, Farias MLF, Madeira M, Vieira Neto L.
    J Clin Endocrinol Metab; 2020 Aug 01; 105(8):. PubMed ID: 32413110
    [Abstract] [Full Text] [Related]

  • 20. Predictors of Tumour Growth and Autonomous Cortisol Secretion Development during Follow-Up in Non-Functioning Adrenal Incidentalomas.
    Araujo-Castro M, Parra Ramírez P, Robles Lázaro C, García Centeno R, Gracia Gimeno P, Fernández-Ladreda MT, Sampedro Núñez MA, Marazuela M, Escobar-Morreale HF, Valderrabano P.
    J Clin Med; 2021 Nov 25; 10(23):. PubMed ID: 34884211
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.